Galecto (GLTO) said late Tuesday it priced an offering of 14.5 million shares at $19 per share.
The pharmaceutical company said it also granted underwriters a 30-day option to purchase up to 2.2 million additional shares.
Gross proceeds are expected to total $275 million and the offering is expected to close Thursday, the company said.
Shares of the company were down 3.7% in Wednesday's premarket trading.